J&J Expects Sales Loss To Be Skin-Deep, Looks To Skin-Care Lines For Boost
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson looks to rebound from its first yearly decline in sales since the Depression in part by capitalizing on momentum in its skin-care business with extensions of its Aveeno, Neutrogena and RoC lines designed to meet anti-aging needs around the clock